During the C. elegans embryonic development, the embryo undergoes dramatic changes to elongate from a spheroid into a long, thin worm. The epidermis of the embryo provides the driving force for elongation. The epidermal cytoskeleton is a highly organized structure of actin microfilaments, microtubules and intermediate filaments. The C. elegans Rho-binding kinase (LET-502) and myosin phosphatase (MEL-11) are essential regulators for the actomyosin-mediated embryonic elongation and act in parallel with FEM-2/PP2c phosphatase and PAK-1/p21 activated kinase (GALLY et al. 2009; PIEKNY et al. 2000). Actin nucleation is the rate limiting step of actin filament polymerization. We previously identified
fhod-1 (formin homology domain), which is highly similar to the human actin nucleators FHOD1 and FHOD3. Our genetic analysis revealed that
fhod-1 acts in the
mel-11/let-502 pathway, in parallel to
fem-2/pak-1.
fhod-1 mutants exhibit less than 25% elongation defects, suggesting redundancy with other formins (or other genes) for actin nucleation. Potential candidates include six other C. elegans formins:
daam-1,
inft-1,
inft-2,
frl-1,
fozi-1 and
cyk-1. Only two of these genes,
inft-1and cyk-1, appear to have a role in elongation based on
let-502 RNAi in mutant backgrounds. Muscle is required for elongation past the 2 fold stage, and perhaps is required redundantly with
let-502/mel-11 at earlier stages. However, we found that the
ilk-1 Pat (paralyzed at two fold) mutant did not suppress
mel-11.